Infantile fibrosarcoma with TPM3-NTRK1 fusion in a boy with Bloom syndrome

Familial Cancer
Sue M HusonStefan Meyer

Abstract

Bloom syndrome (BS) is a genomic and chromosomal instability disorder with prodigious cancer predisposition caused by pathogenic variants in BLM. We report the clinical and genetic details of a boy who first presented with infantile fibrosarcoma (IFS) at the age of 6 months and subsequently was diagnosed with BS at the age of 9 years. Molecular analysis identified the pathogenic germline BLM sequence variants (c.1642C>T and c.2207_2212delinsTAGATTC). This is the first report of IFS related to BS, for which we show that both BLM alleles are maintained in the tumor and demonstrate a TPM3-NTKR1 fusion transcript in the IFS. Our communication emphasizes the importance of long-term follow up after treatment for pediatric neoplastic conditions, as clues to important genetic entities might manifest later, and the identification of a heritable tumor predisposition often leads to changes in patient surveillance and management.

References

Feb 14, 1998·Nature Genetics·S R KnezevichP H Sorensen
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel OrbachAndrea Ferrari
Jun 17, 2014·Journal of Genetic Syndromes & Gene Therapy·Madeleine AdamsStefan Meyer
Sep 12, 2015·Scientific Reports·Richarda M de VoerRoland P Kuiper
Jan 18, 2017·Pediatric Blood & Cancer·Dean PavlickSiraj M Ali
Feb 25, 2017·Molecular Syndromology·Christopher CunniffNathan A Ellis
Oct 24, 2017·European Journal of Medical Genetics·Arjan BoumanPhillis Lakeman
Sep 2, 2018·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Zoran GatalicaSemir Vranic
Oct 20, 2018·Nature Reviews. Clinical Oncology·Emiliano CoccoAlexander Drilon
Sep 21, 2019·Nature Reviews. Disease Primers·A Malcolm R TaylorGrant S Stewart

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Related Papers

Genome Integrity
Shweta Tikoo, Sagar Sengupta
Nihon rinsho. Japanese journal of clinical medicine
Naomi Kondo
© 2021 Meta ULC. All rights reserved